Singapore manufacturing output growth slows to 3.4% in September amid biomedical decline

Singapore's manufacturing output grew by 3.4 per cent year-on-year in September, slowing from 15.4 per cent growth in August, amid a sharp decline in biomedical manufacturing output.

Excluding biomedical manufacturing, output in September increased by 9 per cent, easing from the 16.8 per cent growth in August, according to data from the Economic Development Board (EDB) released on Monday (Oct 26).

On a seasonally adjusted month-on-month basis, manufacturing output decreased 3.9 per cent, compared with a 0.5 per cent decline in August, while output excluding biomedical manufacturing dropped by 5.5 per cent.

Growth in all clusters except chemicals, biomedical manufacturing

EDB data also showed that all clusters recorded growth on a year-on-year basis in September, except chemicals and biomedical manufacturing.

Precision engineering grew 31 per cent, supported by higher production of semiconductor equipment in the machinery and systems segment.

Meanwhile, transport engineering grew by 10.6 per cent, as the land and aerospace segments expanded, with aerospace supported by higher production of aircraft parts and sustained maintenance, repair and overhaul jobs from commercial airlines.

However, this growth was partially offset by lower shipyard activity and lower production of oil and gas field equipment in the marine and offshore engineering segment.

The electronics and general manufacturing sectors recorded growth of 5.7 per cent and 4 per cent respectively.

Chemicals output declined 4.6 per cent, which EDB said was weighed down by the other chemicals segment and petrochemicals segment.

The other chemicals segment recorded lower output of fragrances while petrochemicals production remained constrained by softer demand and feedstock supply disruptions, it explained.

Biomedical manufacturing output fell 32.8 per cent. EDB noted that this was led by the pharmaceuticals segment, which saw a different mix of active pharmaceutical ingredients being produced.

The medical technology segment fell due to softer export demand, it said.

The next monthly manufacturing performance will be released on Nov 26.

新加坡9月份制造业产出同比增长3.4%，增速较8月份的15.4%有所放缓，其中生物医药制造业产出大幅下降。

根据经济发展局（EDB）周一（10月26日）发布的数据，除生物医药制造业外，9月份制造业产出增长9%，低于8月份16.8%的增幅。

经季节调整后，制造业产出环比下降 3.9%，而 8 月份的降幅为 0.5%；若不计入生物医药制造业，则产出下降 5.5%。

除化工和生物医药制造行业外，所有产业集群均实现增长。

EDB 数据显示，除化学品和生物医药制造业外，所有产业集群在 9 月份均实现了同比增长。

精密工程行业增长了 31%，这得益于机械和系统领域半导体设备产量的提高。

与此同时，交通工程行业增长了 10.6%，陆地和航空航天领域均有所扩张，其中航空航天领域受益于飞机零部件产量的提高以及商业航空公司持续的维护、修理和大修工作。

然而，造船厂活动减少以及海洋和近海工程领域油气田设备产量下降，部分抵消了这一增长。

电子行业和一般制造业分别增长了5.7%和4%。

化工产品产量下降了 4.6%，EDB 表示，这是由于其他化工产品和石化产品板块的下滑所致。

报告解释说，其他化学品领域的香料产量有所下降，而石化产品的生产仍然受到需求疲软和原料供应中断的限制。

生物医药制造业产量下降了32.8%。经济发展局指出，这主要是由于制药行业产量下降，该行业生产的活性药物成分组合发生了变化。

报告称，医疗技术板块下滑是由于出口需求疲软所致。

下一次月度制造业业绩报告将于11月26日发布。